On-Demand CME Videos
Difficult Dermatology Conversations: Improving Care for Diverse Patient Populations
About
This activity was reported at the Fall Clinical Dermatology Conference 2023.
Difficult Dermatology Conversations: Improving Care for Diverse Patient Populations
This activity is supported by educational grants from Amgen, Galderma, Incyte, LEO Pharma, Lilly, and L'Oreal.
Availability
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
December 4, 2023
December 31, 2024
Learning Objectives
At the completion of this activity, participants should be better able to:
Identify common dermatoses presentations in patients with skin of color (SOC)
Describe how to assess patients with diverse cultural backgrounds, SOC, and sexual orientation
Review treatment options for common dermatoses seen in diverse patient populations
Employ strategies to effectively communicate with patients with diverse cultural backgrounds, SOC, and sexual orientation
Intended Audience
Faculty
Karan Lal, DO, MS, FAAD
Director of Pediatric and Cosmetic Dermatology
Affiliated Dermatology
Scottsdale, AZ
Jennifer Soung, MD
Director of Clinical Research
Southern California Dermatology
Clinical Faculty
Harbor University of California Los Angeles
Santa Ana, CA
Susan Taylor, MD
Incoming President-elect, American Academy of Dermatology
Bernett L. Johnson Endowed Professor in Dermatology
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Advisory Board: Incyte, Galderma, Aphyn Biologics, Verrica, Cerave
Speaker's Bureau or Honoraria: Abbvie, Galderma, Incyte, Boehringer, Verrica
Advisory Board/Consultant: Arcutis Biotechnology; Bristol Myers Squibb Company; Dermavant Sciences, Inc. Novartis, Abbvie, Lily, Pfizer, LEO Pharma, Regeneron, Sanofi, Amgen, Dermavant, Janssen, UCB
Shareholder: Pfizer
Grant/Research Support: AbbVie Inc.; Amgen Inc.; Arcutis Biotechnology; Castle Biosciences; Dermavant Sciences, Inc.; Janssen Pharmaceuticals, Inc.; KoBio Labs; Kyowa Kirin; LEO Pharma, Inc.; Lilly; Novartis; Pfizer Inc.; UCB Pharma, Inc
Speaker's Bureau: AbbVie Inc.; Amgen Inc.; Arcutis Biotechnology; Bristol Myers Squibb Company; LEO Pharma, Inc.; Lilly; Novartis; Ortho Dermatologics; Pfizer Inc.; Regeneron, Sanofi, Dermavant, Janssen
Advisory Board: AbbVie, Avita Medical, Beiersdorf, Biorez (past), Eli Lilly, EPI Health, Evolus, Galderma, Hugel America, Incyte, Johnson & Johnson, L'Oreal USA, Medscape, Pfizer, Scientis US, UCB, Vichy Laboratoires Grant/Research Support: Allergan Aesthetics, Concert Pharmaceuticals/Sun Pharma, Croma Pharma GmbH, Eli Lilly, Pfizer Consultant: Arcutis, Armis Scientific, Beiersdorf, Bristol Myers Squibb, Cara Therapeutics, Dior, GloGetter, Piction Health, Sanofi Speakers’ Bureau or Honoraria: Beiersdorf, Medscape, MJH Lifesciences Royalty: McGraw Hill Publishing Ownership Interest (privately held): Armis Scientific, GloGetter, Piction Health Other Financial Benefit: Mercer Strategies LLC
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.